Argitalpenak (75) IGNACIO GONZÁLEZ-PINTO ARRILLAGA argitalpenak

2020

  1. Donation after circulatory death liver transplantation: consensus statements from the Spanish Liver Transplantation Society

    Transplant International, Vol. 33, Núm. 8, pp. 902-916

2019

  1. A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain

    Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2008

  1. Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: Results of a prospective randomized study

    Liver Transplantation, Vol. 14, Núm. 12, pp. 1752-1760

  2. Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications

    Clinical Chemistry and Laboratory Medicine, Vol. 46, Núm. 5, pp. 660-666

  3. Primitive neuroectodermal peripheral tumour of the retroperitoneum

    Clinical and Translational Oncology, Vol. 10, Núm. 6, pp. 380-382

2007

  1. Criterios mínimos de trasplante hepático: Child, MELD, excepciones

    Medicina Clinica Monografias, Vol. 8, Núm. 2, pp. 38-41

2006

  1. Corrigendum to "Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized study" [J Hepatol 44 (2006) 710-716] (DOI:10.1016/j.jhep.2005.12.010)

    Journal of Hepatology

  2. El donante con cáncer

    Medicina Clinica Monografias, Vol. 7, Núm. 5, pp. 41-45

  3. Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized study

    Journal of Hepatology, Vol. 44, Núm. 4, pp. 710-716

2005

  1. Choque anafiláctico de origen hepático

    Cirugía Andaluza, Vol. 16, Núm. 3, pp. 13

  2. Five-year follow-up of a trial comparing tacrolimus and cyclosporine microemulsion in liver transplantation

    Transplantation Proceedings

  3. Perspectiva de los sarcomas retroperitoneales: experiencia de un servicio quirúrgico

    Cirugía Andaluza, Vol. 16, Núm. 3, pp. 12

2002

  1. Does hepatic retransplantation entail an increase in the number of early reoperations? A decade of experience

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 303

  2. Early mortality in liver retransplantation: A multivariate analysis of risk factors

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 301-302

  3. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients

    Liver Transplantation, Vol. 8, Núm. 2, pp. 123-131

  4. Liver transplantation in patients with portal thrombosis: Results in 76 patients

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 248-249

2001

  1. A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: Midterm efficacy and safety

    Transplantation Proceedings, Vol. 33, Núm. 7-8, pp. 3439-3441

  2. Complicaciones de las resecciones hepáticas

    Cirugia Espanola, Vol. 69, Núm. 3, pp. 297-303